Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ionis Pharmaceuticals
Pharma
Ionis chalks up phase 3 trial win as it works to grow Tryngolza
Already approved in a rare genetic disorder, Ionis' medicine demonstrated benefits in treating patients with moderate hypertriglyceridemia.
Zoey Becker
May 19, 2025 12:10pm
Takeda, Sun, Ono—Fierce Pharma Asia
Mar 14, 2025 8:45am
Ionis begins first Tryngolza campaigns targeting patients, HCPs
Feb 19, 2025 2:41pm
FDA signs off on Ionis, AZ's rare disease drug Wainua
Dec 22, 2023 8:45am
Ionis to upgrade manufacturing ops with new site in California
Oct 12, 2022 11:07am
